Supreme Court Questions Basis of Lawsuit Against Abortion Drug Mifepristone

The justices express skepticism over anti-abortion doctors' standing in a case that could impact access to medication abortions.

Supreme Court appears skeptical of anti-abortion doctors' claims against FDA's approval of mifepristone, questioning their legal standing.
Mifepristone, a key drug in medication abortions, remains under scrutiny as courts evaluate its FDA approval and subsequent deregulation.
Critics argue the lawsuit against mifepristone lacks scientific basis, citing discredited studies and anonymous blog posts.
The case has sparked broader discussions about the Comstock Act and potential new avenues for restricting access to abortion.
Public and political reactions to the case are divided, with rallies and legislative proposals reflecting deep-seated opinions on abortion.